SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-17-245780
Filing Date
2017-08-02
Accepted
2017-08-02 16:03:40
Documents
6
Period of Report
2017-08-02

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT PERTAINING TO A MERGER d391632dprem14a.htm PREM14A 1426467
2 GRAPHIC g391632dsp105.jpg GRAPHIC 238196
3 GRAPHIC g391632dsp106.jpg GRAPHIC 150643
4 GRAPHIC g391632g09u11.jpg GRAPHIC 20504
5 GRAPHIC g391632g43f80.jpg GRAPHIC 29142
6 GRAPHIC g391632g99t54.jpg GRAPHIC 37398
  Complete submission text file 0001193125-17-245780.txt   2083173
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 000-19825 | Film No.: 17999884
SIC: 2834 Pharmaceutical Preparations